Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers
about
A Sensitized Screen for Genes Promoting Invadopodia Function In Vivo: CDC-42 and Rab GDI-1 Direct Distinct Aspects of Invadopodia FormationRNA-binding protein nucleolin in diseaseMetabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinomaProteomics in pancreatic cancer research.Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Validation of reverse phase protein array for practical screening of potential biomarkers in serum and plasma: accurate detection of CA19-9 levels in pancreatic cancerCurrent status of molecular markers for early detection of sporadic pancreatic cancer.Bioinformatics analysis of Rab GDP dissociation inhibitor beta and its expression in non-small cell lung cancer.Detection of pancreatic cancer using serum protein profiling.The current state of proteomics in GI oncology.Cyclin I is involved in the regulation of cell cycle progressionGenetic and molecular alterations in pancreatic cancer: implications for personalized medicine.Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling.Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma.Serum peptide signatures for pancreatic cancer based on mass spectrometry: a comparison to CA19-9 levels and routine imaging techniques.Proteomics analysis of bodily fluids in pancreatic cancerDifference gel electrophoresis identifies differentially expressed proteins in endoscopically collected pancreatic fluidAdvances in biomarker research for pancreatic cancer.Improved diagnosis of pancreatic adenocarcinoma using haptoglobin and serum amyloid A in a panel screen.Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometryProteomic and metabolic prediction of response to therapy in gastrointestinal cancers.Screening technologies for target identification in pancreatic cancer.Potential for proteomic approaches in determining efficacy biomarkers following administration of fish oils rich in omega-3 fatty acids: application in pancreatic cancers.Proteomic analysis of the aqueous humor in patients with wet age-related macular degeneration.Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach.Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression.A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancer.Proteome analysis of human pancreatic cancer cell lines with highly liver metastatic potential by antibody microarray.SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome."Stealth dissemination" of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma.Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model.Proteome evaluation of human cystic echinococcosis sera using two dimensional gel electrophoresis.Prohibitin: a potential biomarker for tissue-based detection of gastric cancer.Proteomics in pancreatic cancer research
P2860
Q27309256-5CDD8491-741F-4E9B-9CA2-9D1AA3BCFF0AQ28390879-296E1459-8E17-4A32-BD49-A48247B6170DQ28477463-E921693E-7504-4F8C-86FA-7306275E2C8EQ33791981-556BA827-2895-4FE8-B39C-B011E7761719Q33891197-723FB22B-8635-4BA6-BFE7-19C68D1440F1Q34354775-5CEB6BD0-CF0A-46A5-90FA-A16C702ECF2DQ34458903-4471E002-C294-41EF-A31C-654C367C48F9Q34466835-22DEDB6A-3EAF-4108-83AB-71B508AA950DQ34607497-26CD5CA7-E093-4C1C-9A1D-6B9193F200B5Q34608851-0BCD163C-8F7A-4B23-B4E5-D3195F0744B5Q34654891-15926624-2C0F-43AF-B28E-138868C9E6F9Q34657038-4C650E1D-F350-4DCB-941D-046E438023A4Q34958895-36B4A188-5E01-4B55-89EE-3FB7A1CC93CEQ35042544-540D961F-53BF-4069-92C3-54C8C2C7A18DQ35266857-0F9DB116-C6BF-44FE-AB86-AC07697E242AQ35920900-32AF68C6-A109-4B8C-AECB-1C44DCF8031BQ36029032-89089DE8-0235-443E-957D-08D392C111F6Q36126609-E2C1FE55-7F89-4961-9F99-67CF56B6E3D0Q37130537-37CC438E-30E0-4A15-B33C-FE181E7EDB34Q37215561-B103B337-A028-4582-82CC-4AB6E5922DABQ37405931-7F7E29D2-64C7-44B5-974C-62D17591149DQ38161327-38C2C158-59A5-45AE-A0FF-CB27E35722ABQ38330381-901800AA-AFF0-49E6-B850-32406C0BE897Q38492019-905BA65E-FF89-4A59-AB01-2E407DC59947Q38780454-A5856785-0794-46B5-A253-55EB34E2821DQ39021762-6C3AAF47-4A22-4B8C-80F7-664B5F38D8CDQ39452744-A425A77F-02B0-44B5-99AA-BC78775A6214Q39642084-4471D97C-4225-429F-91D1-8E96C75B30C8Q39671092-DA23FE00-1F57-4961-84FE-E8CE44DA0405Q42366169-FB8B3CF6-D1FF-44F2-BC9F-2C9367778EFCQ47793124-B20BFAEC-DDFD-4300-A2A9-F556A6DE8CE5Q52643588-6B9A7989-2D40-4D91-8FC1-1B895270D028Q54519804-4F2614E8-F9D0-49BA-9707-184B8011828FQ58688339-8A19B464-ADDA-4949-9A6C-5CE3A405478B
P2860
Serum proteomic-based analysis of pancreatic carcinoma for the identification of potential cancer biomarkers
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Serum proteomic-based analysis ...... of potential cancer biomarkers
@ast
Serum proteomic-based analysis ...... of potential cancer biomarkers
@en
Serum proteomic-based analysis ...... of potential cancer biomarkers
@nl
type
label
Serum proteomic-based analysis ...... of potential cancer biomarkers
@ast
Serum proteomic-based analysis ...... of potential cancer biomarkers
@en
Serum proteomic-based analysis ...... of potential cancer biomarkers
@nl
prefLabel
Serum proteomic-based analysis ...... of potential cancer biomarkers
@ast
Serum proteomic-based analysis ...... of potential cancer biomarkers
@en
Serum proteomic-based analysis ...... of potential cancer biomarkers
@nl
P2093
P1476
Serum proteomic-based analysis ...... of potential cancer biomarkers
@en
P2093
Fu-Qiang Wang
Ze-Kuan Xu
Zhi-Ling Sun
Zhi-Ning Fan
P304
P356
10.1016/J.BBAPAP.2007.04.001
P407
P577
2007-06-01T00:00:00Z